Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RAS‐targeted cancer therapy: Advances in drugging specific mutations
Cen Liu, Danyang Ye, Hongliu Yang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 18

Showing 18 citing articles:

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
Lei Wang, Wang‐Qing Liu, Sylvain Broussy, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 36
Navigating the ERK1/2 MAPK Cascade
Ana Martín-Vega, Melanie H. Cobb
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1555-1555
Open Access | Times Cited: 35
From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies
Alessandro Ottaiano, Monica Ianniello, Mariachiara Santorsola, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1183-1183
Open Access | Times Cited: 18
Small molecular inhibitors for KRAS-mutant cancers
Xuan Wu, Wenping Song, Cheng Cheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Chinese Medicine for the Treatment of Liver Cirrhosis: The Mechanism of Cellular Autophagy
Shihao Zheng, Tianyu Xue, Qiuyue Wang, et al.
The American Journal of Chinese Medicine (2025), pp. 1-25
Closed Access
Designing drugs and chemical probes with the dualsteric approach
Jinyin Zha, Jixiao He, Chengwei Wu, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 24, pp. 8651-8677
Closed Access | Times Cited: 9
An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review
Ahmed Sabt, Haytham O. Tawfik, Eman F. Khaleel, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display
Mirai Kage, Ryuji Hayashi, Atsushi Matsuo, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117830-117830
Closed Access | Times Cited: 3
Molecular dynamics simulations for the structure-based drug design: targeting small-GTPases proteins
Angela Parise, Sofia Cresca, Alessandra Magistrato
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 10, pp. 1259-1279
Closed Access | Times Cited: 3
Novel KRAS Inhibitors for Treating Non-Small-Cell Lung Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 773-774
Open Access | Times Cited: 1
Designed dualsteric modulators: A novel route for drug discovery
N Li, Guodong Zheng, Lili Fu, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 10, pp. 104141-104141
Closed Access | Times Cited: 1
Imidazopyridine Compounds as ERK5 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 777-778
Open Access | Times Cited: 1
Decoding RAS mutations in thyroid cancer: A meta-analysis unveils specific links to distant metastasis and increased mortality
Isabel Riccio, Alexandra LaForteza, Madeleine B. Landau, et al.
American Journal of Otolaryngology (2024) Vol. 46, Iss. 1, pp. 104570-104570
Open Access | Times Cited: 1
Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with NRAS-mutated metastatic intrahepatic cholangiocarcinoma: a case report
A. A. Musaelyan, E.M. Anokhina Anokhina, Alina I. Turdubaeva, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 3, pp. 780-788
Open Access
Novel KRAS Inhibitors for Treating Non-small Cell Lung Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1201-1202
Open Access
Roles of posttranslational modifications in lipid metabolism and cancer progression
Tianyu Feng, He Zhang, Yanjie Zhou, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?
Fiona Healy, Amy L. Turner, Vanessa Marensi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1

Scroll to top